{"id":481259,"title":"Notice Prescription Drug List (PDL):  Bamlanivimab (COVID-19) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:15:40.397000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/bamlanivimab-covid-19.html?wbdisable=true","snippet":"Notice Prescription Drug List (PDL): Bamlanivimab (COVID-19) Date: November 20, 2020 Our file number: 20-116517-414 The purpose of this Notice of Amendment is to notify about the addition of bamlanivimab to the Prescription Drug List (PDL) for human and veterinary use. The new…","rawSnapshotUrl":"/api/snapshots/raw/481259","browseUrl":"https://replay.healtharchive.ca/job-6/20260106161540/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/bamlanivimab-covid-19.html?wbdisable=true#ha_snapshot=481259","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}